Featured Article

The 20 Biggest Advances in Tech Over the Last 20 Years

Despite what you may read in the newspapers or see on TV, humans continue to reach new heights of prosperity.

Another decade is over. With the 2020s upon us, now is the perfect time to reflect on the immense technological advancements that humanity has made since the dawn of the new millennium.

This article explores, in no particular order, 20 of the most significant technological advancements we have made in the last 20 years…click here for full article.

Cancer cure – can we afford it?

The biomedical community has a lot to be excited about as the “cure” for cancer gets closer than ever. It may now be in sight, with just a bit more testing, fine tuning, and approvals required. The new treatments are achieving cure rates above 80%, and achieving it with patients who have not responded to more traditional treatments, like…click for full article.

World’s first 3D-printed neighborhood unveiled in Mexico

We’ve followed New Story’s efforts to create affordable 3D-printed homes for a while, including its first prototype model and ambitious plan to build a community in Latin America. That plan has now been put into action and the non-profit has revealed what it calls the world’s first 3D-printed community, which is currently under construction in…Click here for full article.

What’s Driving the Decline in the Goods-Based Sector, After the Boom of 2018?

Services are growing at a decent pace, though more slowly than a year ago. The labor market is the strongest in years, so consumer spending is growing at a good pace, including retail sales, driven by red-hot ecommerce sales. Where the economy is in trouble is in industrial goods and in the huge oil-and-gas sector which also drags down the manufacturing segments that supply it with heavy equipment, tech equipment, vehicles, chemicals, and the like. And I have a couple of special thoughts on the consumer side, concerning apparel sales.

We’ll look at this situation via the detailed wholesale trade report by the Census Bureau, released today. Total wholesales in October fell 1.4% from October last year, to $494.3 billion, below where they’d first been in May 2018. It was the sixth month in a row of year-over year declines and the largest such decline since 2016, and it follows the boom last year when year-over-year sales growth peaked in May at nearly 11%…CLICK for complete article

New genes for you?

The idea behind gene and cell therapy is to introduce organic material into a body that needs help. Bone marrow transplants, also known as stem cell transplants, infuse either your own stem cells (autologous) or someone else’s stem cells (allogeneic) into your body. This is done when your bone marrow no longer produces healthy blood cells, often a result of cancer treatments (chemotherapy). Stem cell infusion enables the body to once again produce healthy blood cells.

Stem cell therapy is well established in mainstream medicine. However, gene therapy has lagged behind, as the research is difficult, and one infamous human test failed badly, ending in the death of the patient. The idea with gene therapy is to introduce a healthy gene into the body, replacing all of the unhealthy genes, such as the gene that causes Cystic Fibrosis. The idea is sound in that we can now positively identify problem genes and we can identify and isolate good genes to replace them with. The really difficult part is finding a safe and effective way to…Click to read full article.

Are Cannabis Stocks Finally a Steal of a Deal?

Growth investing can be extremely challenging, especially when the stocks in which you are investing have no earnings. Speculative cannabis investors have been taught a harsh lesson over the course of the past year, with many of these stocks being absolutely crushed in the latter half of 2019. How bad has it been? Well, let’s look at some of the performances of some of the better-known stocks over the past year.

Cannabis stocks have been crushed

The better-known stocks in the Canadian cannabis space are AphriaAurora Cannabis, and Canopy Growth. It is interesting to note that there is not one single stock among the bunch that has survived the carnage. Not a single stock has the investor clout and financial strength.

Every single stock has basically been cut in half or more over the past year. Aphria has fallen almost 48% from a year ago. Aurora has fallen even more, down 55% year over year. Even Canopy Growth, which was arguably the biggest and best of the bunch, is down 45% at the time of this writing.

Even owning a basket of stocks wouldn’t have helped much over this time frame. Horizons Marijuana Life Sciences ETF has been similarly crushed, down almost 48% over the same period. You have to realize how big an issue this is, since an ETF is usually a good way to mitigate a loss by diversifying….CLICK for complete article